JOSEPH RAEVIS
Ophthalmology Physician · LITTLE SILVER, NJ
Individual Active NPI 1508253048
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 738 | 25,084 | $3,591,999 | $2,388,859 | $1,880,997 |
| 2023 | 615 | 13,830 | $1,839,679 | $1,187,288 | $941,432 |
| 2022 | 317 | 1,543 | $517,883 | $139,305 | $106,152 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 15,480 | $35 | $28 |
| 92134 | Imaging of retina | 1,297 | $42 | $32 |
| 67028 | Injection of drug into eye | 1,128 | $133 | $102 |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 1,020 | $147 | $117 |
| J0178 | Injection, aflibercept, 1 mg | 944 | $825 | $657 |
| J0177 | Injection, aflibercept hd, 1 mg | 584 | $332 | $265 |
| 92250 | Photography of the retina | 581 | $39 | $30 |
| 92014 | Established patient complete exam of visual system | 575 | $133 | $98 |
| 92012 | Established patient problem focused exam of visual system | 574 | $94 | $67 |
| J7999 | Compounded drug, not otherwise classified | 353 | $83 | $66 |
| 99213 | Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 324 | $96 | $75 |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 235 | $198 | $158 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | 70542 | WI |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in New Jersey
- NPI 1851516983
- NPI 1598700734
- NPI 1396781506
- NPI 1437179942
- NPI 1639507270
- NPI 1003033689
- NPI 1891374369
- NPI 1932719267
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.